---
title: "OpenAI Researcher Miles Wang in Talks to Launch AI Drug Discovery Startup Valued at $2B"
source: "TechCrunch：AI（RSS）"
source_tier: "t2"
url: "https://techcrunch.com/2026/07/14/openai-researcher-miles-wang-in-talks-to-launch-ai-drug-discovery-startup-valued-at-2b/"
permalink: "https://feed.astralor.com/items/itm_26ddb907f98c77b21c59f417"
published: "2026-07-15T00:27:04.000Z"
score: 72
channel: "finance"
tags: ["AI Drug Discovery","Miles Wang","OpenAI","Startup","Life Sciences"]
---

# OpenAI Researcher Miles Wang in Talks to Launch AI Drug Discovery Startup Valued at $2B

## AI commentary

> This story is worth watching because it reaffirms the trend of AI talent moving from foundational model research to vertical applications. For AI practitioners, it's a career path reference; for biopharma investors, it's another signal validating the heat of the track.

## At a glance

According to TechCrunch, OpenAI researcher Miles Wang is in talks to launch an AI drug discovery startup valued at up to $2 billion. This highlights continued investor interest in AI-driven life science breakthroughs and the trend of top AI talent moving into biotechnology.

## Key points

- Miles Wang, current OpenAI researcher, plans to leave and found an AI drug discovery company.
- The startup is valued at approximately $2 billion, attracting multiple VCs.
- This reflects a shift of AI talent from general models to vertical applications like pharma.
- AI in drug discovery has seen active fundraising but technical validation remains key.

## Full text

The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.

---

Verify against the original before citing; curated by Astral Feed: https://feed.astralor.com/items/itm_26ddb907f98c77b21c59f417